Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam vs propofol induction for cerebral blood flow and oxygen saturation in elderly CEA patients
ChiCTR2300070370Phase 4Completed
- Sponsor
- Suzhou Dushu Lake Hospital
- Start
- May 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of remimazolam and propofol in carotid atheroma (CAS) (2 arms), sponsored by Suzhou Dushu Lake Hospital. Primary endpoints: Cerebral oxygen saturation (StO2) and Mean blood flow velocity in middle cerebral artery (Vm). Started May 2021; status: completed.
02
Drugs
remimazolampropofol
03
Conditions
carotid atheroma (CAS)
Beyond the preview
Go deeper on ChiCTR2300070370.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300070370.